Clinical Scorecard: A Prospective Surgical Assessment of the Co-occurrence of Endometriosis and Interstitial Cystitis/Bladder Pain Syndrome

At a Glance

Key Highlights

• Endometriosis affects 10–15% of women of reproductive age.
• Chronic pelvic pain (CPP) is reported in up to 80% of women with endometriosis.
• Diagnosis often takes 8 to 10 years, necessitating improved screening methods.
• First-line management includes medical therapy with contraceptives or progestins.
• Surgical intervention is considered second-line therapy based on symptoms and reproductive desires.

Guideline-Based Recommendations

Diagnosis

• Utilize structured screening questionnaires and high-resolution imaging for non-invasive prediction.

Management

• First-line treatment with combined oral contraceptives or progestin-based therapies.

Monitoring & Follow-up

• Monitor for pain persistence and central sensitization post-treatment.

Risks

• Delayed diagnosis can lead to chronic pain and significant quality of life impairments.

Patient & Prescribing Data

Women with endometriosis and chronic pelvic pain.

Timely initiation of therapy is critical to prevent pain chronification.

Clinical Best Practices

• Implement multimodal clinical frameworks for diagnosis.
• Consider phenotype-based classification for individualized management.
• Address potential co-occurrence of interstitial cystitis/bladder pain syndrome.

Related Resources & Content

• American College of Obstetricians and Gynecologists (ACOG)
• European Society of Human Reproduction and Embryology (ESHRE)
• American Society for Reproductive Medicine (ASRM)